Equities

India Glycols Ltd

INDIAGLYCO:NSI

India Glycols Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)793.45
  • Today's Change-1.55 / -0.19%
  • Shares traded37.45k
  • 1 Year change+26.00%
  • Beta1.1629
Data delayed at least 15 minutes, as of May 23 2024 11:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

India Glycols Limited is an India-based company, which is engaged in manufacturing green technology-based bulk, specialty and performance chemicals and natural gums, spirits, industrial gases, sugar and nutraceuticals. The Company's segments include Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma. The Bio-based Specialities and Performance Chemicals segment comprises glycols, specialty chemicals, natural gum and other related goods. The Potable Spirits segment is engaged in the manufacturing and sale of ethyl alcohol (potable). The Ennature Biopharma segment is engaged in the manufacturing and sale of nutraceutical products. It has a product range that covers a variety of specialties and herbal products, such as nutraceuticals, phytochemicals, biopolymers, mainly Polygalactomannans, industrial gases and liquor. It serves various industries, such as automotive, detergents, healthcare and food processing, mining, and oil and gas, among others.

  • Revenue in INR (TTM)74.98bn
  • Net income in INR1.71bn
  • Incorporated1983
  • Employees1.28k
  • Location
    India Glycols Ltd2B, Sector-126, Noida, Gautam Budh NagarNOIDA 201304IndiaIND
  • Phone+91 1 206860000
  • Fax+91 1 203090111
  • Websitehttps://www.indiaglycols.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Madhya Bharat Agro products Ltd8.17bn248.45m20.50bn308.0082.365.8438.052.512.842.8493.8940.051.062.654.24--3.2111.395.6618.1431.7833.313.049.250.7862.570.45244.09-16.8147.74-80.0016.79137.8731.95
Vishnu Chemicals Ltd12.48bn1.09bn21.19bn422.0018.28--15.101.7017.7017.70200.84--------29,577,610.00--7.30--12.9430.0535.318.736.53--4.62--2.8030.1216.3567.7856.7728.8614.87
Yasho Industries Ltd5.93bn579.34m21.24bn659.0036.587.2128.883.5850.9450.94521.75258.540.72232.515.32--7.059.0510.3215.6635.9333.649.768.350.59625.650.6627---11.6111.78-14.6337.2658.12--
Panama Petrochem Ltd.21.26bn1.85bn21.35bn156.0011.54--10.981.0030.5830.58351.50--------136,292,900.00--13.51--23.5417.0920.038.708.39--16.13--18.175.4610.811.1430.7513.7746.14
IOL Chemicals and Pharmaceuticals Ltd.21.33bn1.34bn21.73bn2.56k16.161.3511.011.0222.9022.90363.33274.490.99983.724.37--6.3014.918.2719.4534.5034.796.3012.001.2410.410.0199---3.804.82-3.39-10.7035.27--
Astec LifeSciences Limited4.58bn-469.30m22.36bn551.00--6.05--4.88-23.94-23.94234.09188.320.46891.302.83---4.804.71-9.109.7330.3230.66-10.236.380.5102-1.670.572---27.061.24-283.57--20.75--
Bhagiradha Chemicals and Industries Ltd4.19bn203.95m22.49bn467.0094.09--72.305.371.921.9238.89--------8,971,398.00--8.84--14.3838.8525.764.876.84--5.12----15.2521.8826.31--26.58--
Foseco India Ltd4.89bn745.94m23.00bn225.0030.83--27.714.70116.80116.80765.70------------13.76--19.8245.7539.2615.2511.35--671.05--32.9117.385.6858.7717.909.290.00
Sigachi Industries Ltd3.67bn494.13m23.96bn1.03k49.66--40.826.521.471.4711.07--------3,551,738.00--18.15--24.6352.7849.4313.4515.12--10.02--0.0020.6824.438.7449.6487.10--
India Glycols Ltd74.98bn1.71bn24.68bn1.28k14.42--8.970.329155.2655.262,421.80--------58,398,440.00--3.79--6.6610.5610.732.282.71--2.85--12.440.60959.80-62.055.3227.6413.40
Tatva Chintan Pharma Chem Ltd3.94bn303.54m26.20bn608.0084.153.5546.826.6613.3113.31171.88315.100.49891.105.10--3.8510.544.8214.6155.7446.397.7114.431.826.520.0195.17-7.1113.79-33.278.1267.37--
Premier Explosives Limited2.37bn240.15m26.32bn822.00109.69--75.0211.0922.3222.32220.46--------2,886,219.00--0.159--0.229262.0347.0210.140.2542--3.67----1.46-6.3430.32-3.25-1.93-7.42
Thirumalai Chemicals Ltd20.83bn-387.90m26.75bn526.00--2.34109.601.28-3.79-3.79203.73111.900.73345.8414.61---1.375.26-2.057.5220.1226.26-1.865.640.8583-0.2920.52219.92-2.3010.56-143.18--33.22-12.94
India Pesticides Ltd7.52bn891.33m27.92bn280.0031.21--27.033.717.777.7765.60--------26,866,790.00--------41.48--11.85----24.73----23.57---9.32------
Data as of May 23 2024. Currency figures normalised to India Glycols Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

2.90%Per cent of shares held by top holders
HolderShares% Held
Aditya Birla Sun Life Insurance Co. Ltd.as of 30 Jun 2023563.18k1.82%
Dimensional Fund Advisors LPas of 09 May 2024271.55k0.88%
Motilal Oswal Asset Management Co. Ltd.as of 30 Apr 202419.53k0.06%
American Century Investment Management, Inc.as of 09 May 202414.89k0.05%
Dimensional Fund Advisors Ltd.as of 29 Feb 202413.89k0.05%
SSgA Funds Management, Inc.as of 09 May 202410.42k0.03%
DFA Australia Ltd.as of 31 Mar 20242.63k0.01%
Mellon Investments Corp.as of 09 May 2024341.000.00%
Groww Asset Management Ltd.as of 30 Apr 202488.000.00%
More ▼
Data from 31 Mar 2024 - 16 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.